<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
     version="2.0">
   <channel>
      <title>Wiley: Genes, Brain and Behavior: Table of Contents</title>
      <link>https://onlinelibrary.wiley.com/journal/1601183x?af=R</link>
      <description>Table of Contents for Genes, Brain and Behavior. List of articles from both the latest and EarlyView issues.</description>
      <language>en-US</language>
      <copyright>© John Wiley &amp; Sons Ltd and International Behavioural and Neural Genetics Society</copyright>
      <managingEditor>wileyonlinelibrary@wiley.com (Wiley Online Library)</managingEditor>
      <pubDate>Mon, 08 Jun 2026 08:08:54 +0000</pubDate>
      <lastBuildDate>Mon, 08 Jun 2026 08:08:54 +0000</lastBuildDate>
      <generator>Atypon® Literatum™</generator>
      <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
      <ttl>10080</ttl>
      <dc:title>Wiley: Genes, Brain and Behavior: Table of Contents</dc:title>
      <dc:publisher>Wiley</dc:publisher>
      <prism:publicationName>Genes, Brain and Behavior</prism:publicationName>
      <atom:link href="https://onlinelibrary.wiley.com/journal/1601183x?af=R"
                 rel="self"
                 type="application/atom+xml"/>
      <image>
         <title>Wiley: Genes, Brain and Behavior: Table of Contents</title>
         <url>https://onlinelibrary.wiley.com/pb-assets/journal-banners/1601183x.jpg</url>
         <link>https://onlinelibrary.wiley.com/journal/1601183x?af=R</link>
      </image>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1111/gbb.70053?af=R</link>
         <pubDate>Mon, 18 May 2026 02:30:47 -0700</pubDate>
         <dc:date>2026-05-18T02:30:47-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/1601183x?af=R">Wiley: Genes, Brain and Behavior: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1111/gbb.70053</guid>
         <title>Genetic Architecture of Addiction‐Relevant Behaviors in Outbred Sprague–Dawley Rats Reveals Loci for Anxiety‐Like and Nociceptive Traits</title>
         <description>Genes, Brain and Behavior, Volume 25, Issue 3, June 2026. </description>
         <dc:description>
Genome‐wide association analyses in outbred Sprague–Dawleys identified loci for anxiety‐like and nociceptive behavior on chromosomes 1, 14, and 17, which are distinct from facets of exploratory locomotion significant in our GWAS of a F2 intercross of selectively bred high‐ and low‐responder (to a novel environment) Sprague–Dawleys.

ABSTRACT
Studies have shown that substance use liability is associated with novelty seeking, anxiety‐like behavior, and pain sensitivity. We examined whether common genetic variation in outbred Sprague–Dawley rats explained variation in behavioral measures from three assays with established links to substance use: locomotor response to a novel environment, elevated plus maze, and tail flick. We estimated single‐nucleotide polymorphism heritability and performed genome‐wide association analyses using permutation‐derived significance thresholds (N = 534–654 rats across traits). Heritability estimates ranged from 0.14 to 0.38 across 11 traits. Three independent loci were identified: chromosome 1 for elevated plus maze open‐arm behavior (α = 0.05), chromosome 14 for elevated plus maze immobility (α = 0.10), and chromosome 17 for tail flick latency (α = 0.05). Candidate genes included Slc18a2, Gfra1, and Pdzd8 (chromosome 1); Rel and Bcl11a (chromosome 14); and Eci2 and Eci3 (chromosome 17). We compared these loci with our genome‐wide association study of a F2 intercross of selectively bred high‐ and low‐responder rats, originally derived from Sprague–Dawleys, that model individual differences in externalizing and internalizing behavior. The current loci are distinct from the ones identified in the bred lines. This difference likely reflects selection history in the high‐ and low‐responder F2s, which focused on facets of exploratory locomotion, while loci for anxiety and pain sensitivity traits were identified in the outbreds. This highlights the benefit of using both outbred and selectively bred rats to probe causal variants contributing to individual differences in substance use liability. The current outbred findings implicate monoaminergic signaling, transcriptional control, and lipid metabolism as testable mechanisms for addiction‐relevant behaviors.
</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/a49b8d67-4b9f-4ba8-b07a-f11822d77a70/gbb70053-toc-0001-m.png"
     alt="Genetic Architecture of Addiction-Relevant Behaviors in Outbred Sprague–Dawley Rats Reveals Loci for Anxiety-Like and Nociceptive Traits"/&gt;
&lt;p&gt;Genome-wide association analyses in outbred Sprague–Dawleys identified loci for anxiety-like and nociceptive behavior on chromosomes 1, 14, and 17, which are distinct from facets of exploratory locomotion significant in our GWAS of a F&lt;sub&gt;2&lt;/sub&gt; intercross of selectively bred high- and low-responder (to a novel environment) Sprague–Dawleys.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;p&gt;Studies have shown that substance use liability is associated with novelty seeking, anxiety-like behavior, and pain sensitivity. We examined whether common genetic variation in outbred Sprague–Dawley rats explained variation in behavioral measures from three assays with established links to substance use: locomotor response to a novel environment, elevated plus maze, and tail flick. We estimated single-nucleotide polymorphism heritability and performed genome-wide association analyses using permutation-derived significance thresholds (&lt;i&gt;N&lt;/i&gt; = 534–654 rats across traits). Heritability estimates ranged from 0.14 to 0.38 across 11 traits. Three independent loci were identified: chromosome 1 for elevated plus maze open-arm behavior (&lt;i&gt;α&lt;/i&gt; = 0.05), chromosome 14 for elevated plus maze immobility (&lt;i&gt;α&lt;/i&gt; = 0.10), and chromosome 17 for tail flick latency (&lt;i&gt;α&lt;/i&gt; = 0.05). Candidate genes included &lt;i&gt;Slc18a2&lt;/i&gt;, &lt;i&gt;Gfra1&lt;/i&gt;, and &lt;i&gt;Pdzd8&lt;/i&gt; (chromosome 1); &lt;i&gt;Rel&lt;/i&gt; and &lt;i&gt;Bcl11a&lt;/i&gt; (chromosome 14); and &lt;i&gt;Eci2&lt;/i&gt; and &lt;i&gt;Eci3&lt;/i&gt; (chromosome 17). We compared these loci with our genome-wide association study of a F&lt;sub&gt;2&lt;/sub&gt; intercross of selectively bred high- and low-responder rats, originally derived from Sprague–Dawleys, that model individual differences in externalizing and internalizing behavior. The current loci are distinct from the ones identified in the bred lines. This difference likely reflects selection history in the high- and low-responder F&lt;sub&gt;2&lt;/sub&gt;s, which focused on facets of exploratory locomotion, while loci for anxiety and pain sensitivity traits were identified in the outbreds. This highlights the benefit of using both outbred and selectively bred rats to probe causal variants contributing to individual differences in substance use liability. The current outbred findings implicate monoaminergic signaling, transcriptional control, and lipid metabolism as testable mechanisms for addiction-relevant behaviors.&lt;/p&gt;</content:encoded>
         <dc:creator>
Apurva S. Chitre, 
Elaine K. Hebda‐Bauer, 
Michael A. Emery, 
Fei Li, 
Khai‐Minh Nguyen, 
Yizhi Wang, 
Riyan Cheng, 
Oksana Polesskaya, 
Stanley J. Watson Jr, 
Jun Li, 
Huda Akil, 
Abraham A. Palmer
</dc:creator>
         <category>ORIGINAL ARTICLE</category>
         <dc:title>Genetic Architecture of Addiction‐Relevant Behaviors in Outbred Sprague–Dawley Rats Reveals Loci for Anxiety‐Like and Nociceptive Traits</dc:title>
         <dc:identifier>10.1111/gbb.70053</dc:identifier>
         <prism:publicationName>Genes, Brain and Behavior</prism:publicationName>
         <prism:doi>10.1111/gbb.70053</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1111/gbb.70053?af=R</prism:url>
         <prism:section>ORIGINAL ARTICLE</prism:section>
         <prism:volume>25</prism:volume>
         <prism:number>3</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1111/gbb.70052?af=R</link>
         <pubDate>Mon, 04 May 2026 09:11:51 -0700</pubDate>
         <dc:date>2026-05-04T09:11:51-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/1601183x?af=R">Wiley: Genes, Brain and Behavior: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1111/gbb.70052</guid>
         <title>Issue Information</title>
         <description>Genes, Brain and Behavior, Volume 25, Issue 3, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator/>
         <category>ISSUE INFORMATION</category>
         <dc:title>Issue Information</dc:title>
         <dc:identifier>10.1111/gbb.70052</dc:identifier>
         <prism:publicationName>Genes, Brain and Behavior</prism:publicationName>
         <prism:doi>10.1111/gbb.70052</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1111/gbb.70052?af=R</prism:url>
         <prism:section>ISSUE INFORMATION</prism:section>
         <prism:volume>25</prism:volume>
         <prism:number>3</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1111/gbb.70051?af=R</link>
         <pubDate>Mon, 04 May 2026 09:09:45 -0700</pubDate>
         <dc:date>2026-05-04T09:09:45-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/1601183x?af=R">Wiley: Genes, Brain and Behavior: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1111/gbb.70051</guid>
         <title>∆FOSB in the Nucleus Accumbens Core Is Required for Increased Anxiety, but Not Decreased Social Motivation, Following Estrogen Withdrawal in Female Mice</title>
         <description>Genes, Brain and Behavior, Volume 25, Issue 3, June 2026. </description>
         <dc:description>
In female mice, estrogen withdrawal following a hormone‐simulated pseudopregnancy is associated with increased levels of ∆FOSB in the Nucleus Accumbens Core and increased anxiety behaviors. However, using viral‐mediated expression of ∆JUND to decrease ∆FOSB‐mediated transcription in the Nucleus Accumbens Core prevents the increase in anxiety following estrogen withdrawal.

ABSTRACT
During pregnancy, estrogen levels rise dramatically, but quickly drop to prepartum levels following birth and remain suppressed until ovulation resumes. This “postpartum estrogen withdrawal” state has been linked to changes in the brain and behavior in humans and rodents. Previous research has demonstrated that following a hormone‐simulated pseudopregnancy (HSP), an experimental model of postpartum estrogen withdrawal, female mice show increased anxiety‐like behaviors and decreased social motivation. Further, these behavioral changes occur concurrently with an increase in ∆FOSB, a transcription factor associated with stable long‐term plasticity, in the nucleus accumbens core. To test whether this increase in ∆FOSB is required for these behavioral changes, we used a viral‐mediated gene transfer approach to prevent ∆FOSB‐mediated transcription in the NAcC during HSP and found that it reduced the high‐anxiety behavioral phenotype in estrogen‐withdrawn females. However, preventing ∆FOSB‐mediated transcription had little effect on social motivation. Together, these results suggest that postpartum estrogen withdrawal increases ∆FOSB in the NAc core to impact anxiety‐like behaviors but not social motivation following estrogen withdrawal.
</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/91604ef2-cfdf-4935-b51e-38c778d094b0/gbb70051-toc-0001-m.png"
     alt="∆FOSB in the Nucleus Accumbens Core Is Required for Increased Anxiety, but Not Decreased Social Motivation, Following Estrogen Withdrawal in Female Mice"/&gt;
&lt;p&gt;In female mice, estrogen withdrawal following a hormone-simulated pseudopregnancy is associated with increased levels of ∆FOSB in the Nucleus Accumbens Core and increased anxiety behaviors. However, using viral-mediated expression of ∆JUND to decrease ∆FOSB-mediated transcription in the Nucleus Accumbens Core prevents the increase in anxiety following estrogen withdrawal.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;p&gt;During pregnancy, estrogen levels rise dramatically, but quickly drop to prepartum levels following birth and remain suppressed until ovulation resumes. This “postpartum estrogen withdrawal” state has been linked to changes in the brain and behavior in humans and rodents. Previous research has demonstrated that following a hormone-simulated pseudopregnancy (HSP), an experimental model of postpartum estrogen withdrawal, female mice show increased anxiety-like behaviors and decreased social motivation. Further, these behavioral changes occur concurrently with an increase in ∆FOSB, a transcription factor associated with stable long-term plasticity, in the nucleus accumbens core. To test whether this increase in ∆FOSB is required for these behavioral changes, we used a viral-mediated gene transfer approach to prevent ∆FOSB-mediated transcription in the NAcC during HSP and found that it reduced the high-anxiety behavioral phenotype in estrogen-withdrawn females. However, preventing ∆FOSB-mediated transcription had little effect on social motivation. Together, these results suggest that postpartum estrogen withdrawal increases ∆FOSB in the NAc core to impact anxiety-like behaviors but not social motivation following estrogen withdrawal.&lt;/p&gt;</content:encoded>
         <dc:creator>
Willow Clayton, 
May Y. Courtney, 
Lilah E. Craig, 
Helen E. Moniz, 
Alison B. Gibbons, 
Alissa A. Valentine, 
Achint K. Singh, 
Dylan R. Gearinger, 
Eric J. Nestler, 
Laura E. Been
</dc:creator>
         <category>ORIGINAL ARTICLE</category>
         <dc:title>∆FOSB in the Nucleus Accumbens Core Is Required for Increased Anxiety, but Not Decreased Social Motivation, Following Estrogen Withdrawal in Female Mice</dc:title>
         <dc:identifier>10.1111/gbb.70051</dc:identifier>
         <prism:publicationName>Genes, Brain and Behavior</prism:publicationName>
         <prism:doi>10.1111/gbb.70051</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1111/gbb.70051?af=R</prism:url>
         <prism:section>ORIGINAL ARTICLE</prism:section>
         <prism:volume>25</prism:volume>
         <prism:number>3</prism:number>
      </item>
   </channel>
</rss>
